ArticlePoultry science2026
Does Salmonella co-infection worsen Histomonas meleagridis infection in turkeys?
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effect of dietary wheat on the progression of Histomonas meleagridis infection in turkey poults.Poultry science · 2026Article
- Wheat levels have minor effects on the progression of coccidiosis in turkey poults.Poultry science · 2026Article
- Comment on "Does Salmonella co-infection worsen Histomonas meleagridis infection in Turkeys?"Poultry science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Histomoniasis, caused by Histomonas meleagridis (HM), leads to severe cecal and hepatic damage in turkeys. Although Salmonella Typhimurium (ST) commonly colonizes in the cecum, its influence on the progression of Histomoniasis remains unclear. This study was conducted to evaluate whether ST co-infection alters clinical outcomes, intestinal integrity, or performance in HM-challenged turkey poults. A total of 336 one-day-old male poults were allocated into four treatments in a 2 × 2 factorial design with 6 replicates/treatment. Negative control (NC), HM challenge (T1), ST challenge (T2), and HM+ST challenge (T3). Birds were inoculated at d 18 and monitored for performance, mortality, lesions, gut permeability, Salmonella colonization, intestinal morphology, and hepatic apoptosis-related gene expression. HM challenge significantly reduced body weight, body weight gain, and feed intake while increasing FCR, mortality, and cecal and hepatic lesion scores (P < 0.01). ST challenge alone caused strong cecal colonization but remained subclinical, with no effect on performance, gut permeability (d28), clinical score, or lesion development. No HM × ST interaction effects were detected for performance, mortality, gut integrity, or lesion severity. ST colonization levels were unaffected by HM co-infection. Histologically, HM reduced duodenal villus height and markedly increased cecal muscularis thickness, whereas ST caused only mild changes, with limited interaction effects that did not translate to worsened disease symptoms. Liver apoptosis-related gene expression analyses showed reduced mRNA expression of BAX and Caspase-3 in all challenged groups compared with the NC, while BCL-2 mRNA expression was elevated only in co-infected poults; however, these transcriptional changes were not accompanied by corresponding differences in pathological outcomes. In conclusion, HM was the primary driver of the disease, impairing growth and inducing severe lesions, whereas ST behaved as a subclinical colonizer that did not intensify Histomoniasis. These findings indicate that ST does not worsen HM-induced performance loss, lesions, or mortality under the current challenge model, reinforcing that ST remains a food-safety concern rather than a major contributor to Histomoniasis severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.